Zvra Stock Analysis Zevra Therapeutics Inc. Biotech Rises 2.36 Percent To 9.54 20260401 1 Microsoft Projects 190 Billion in 2026 Capital Spending Amid Soaring Memory Prices Affordable Housing Finance Stocks Could Rally Up to 34 Bernstein Suggests Nokia Secures UK Appeal Victory Blocking Acer and Asus Video Patent Lawsuits Cotton Futures Display Mixed Performance Amid Midday Trading on Tuesday Bill Gates Discusses Trump Meeting Musks DOGE in WSJ Interview Ahead of Memoir Vestas Wind Systems Shares Decline as Company Warns Margins Near Low End of Guidance ESI Q1 2026 Earnings EPS Surprise Beats Estimates Stock Rises NU Q1 2026 Earnings EPS Misses Expectations Despite Positive Stock Reaction CLMT Q1 2026 Earnings Staggering EPS Miss Overshadowed by Positive Stock Movement Addus HomeCare Corporation ADUS Q1 2026 Earnings EPS Beat Partially Offsets Cautious Stock Reaction IPWR Q1 2026 Earnings EPS Misses Estimates as Stock Declines 167 Adamas Trust Senior Notes ADAMI Edge Lower as Price Hovers Near Midpoint of Range NioCorp NB Edges lower Holding Near Key Support Amid Sector Headwinds Ispire Technology ISPR Drops Nearly 8 as Selling Pressure Builds BHFAP Preferred Shares Edge Lower Amid Narrow Trading Range Borosil Glass Works Shares Surge Over 200 in a Year on Strong Revenue Growth Ethos Technologies Inc LIFE Q1 2026 Earnings EPS Surges 138 Above Estimate Yet Stock Declines Sharply